Trial Profile
A multicenter, randomized controlled trial for the efficacy and safety of tocilizumab in the treatment of new coronavirus pneumonia (COVID-19)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 17 Jun 2020
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- 11 Mar 2020 New trial record